EXACT Sciences (EXAS)

Add a New Bears Reason Company: EXACT Sciences (EXAS) Current price: Headline: (100 character max) Analysis: Cancel 0% agree 0 votes   Clinical data not there yet Top Contributor: Jerry Greenhoot | Created when NASDAQ:EXAS was $3.15 | Edit | History None of this argues against the company in the future, but for now, it's a long term risky investment that may pay off later, and better to keep an eye on than pony up an investment, right now. Follow the clinical science....when clinical studies show a value, then buy it. AFTER ACS guidelines include this technology and Medicare reimbursement is more assured, it'll be a play. (100 character max) Cancel 0% agree 1 votes   Still doesn't let you avoid a colonoscopy Top Contributor: Jerry Greenhoot | Created when NASDAQ:EXAS was $3.15 | Edit | History There's little doubt the science is intriguing. However, the issues of clinical relevance haven't been established. If an abnormality is found here, colonoscopy must be done, so unless an improvement in outcome can be demonstrated in clinical trials of this plus colonoscopy vs. scheduled colonoscopy alone, there'll be an added cost, and an inhibition to use. (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.